tradingkey.logo
tradingkey.logo
Buscar

Bionano Genomics Inc

BNGO
Añadir a la lista de seguimiento
1.150USD
-0.020-1.71%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
12.35MCap. mercado
PérdidaP/E TTM

Más Datos de Bionano Genomics Inc Compañía

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Información de Bionano Genomics Inc

Símbolo de cotizaciónBNGO
Nombre de la empresaBionano Genomics Inc
Fecha de salida a bolsaAug 01, 2018
Director ejecutivoHolmlin (R. Erik)
Número de empleados98
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 01
Dirección9540 Towne Centre Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Teléfono18588887600
Sitio Webhttps://bionano.com/
Símbolo de cotizaciónBNGO
Fecha de salida a bolsaAug 01, 2018
Director ejecutivoHolmlin (R. Erik)

Ejecutivos de Bionano Genomics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Bionano Genomics Inc?

Los cinco principales accionistas de Bionano Genomics Inc son: Mr. Mark Oldakowski

¿Cuántas instituciones poseen acciones de Bionano Genomics Inc (BNGO)?

A fecha de 2026Q1, 109 instituciones poseen acciones de Bionano Genomics Inc, con un valor de mercado combinado de aproximadamente 1.17M, lo que representa el 10.52% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 32263.00.

¿Cuál es la mayor fuente de ganancias de Bionano Genomics Inc?

El 2026Q1, el segmento empresarial Consumables generó la ganancia más alta para Bionano Genomics Inc, ascendiendo a 13.97M y representando el 49.00% de la ganancia total.